Position in NEO
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$1,867
New position
Shares Held
128
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#235
of 265 holders
Holding Since
Jun 2026
1 quarter on record
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fulcrum Asset Management LLP holds $8,929,864 across 7 Diagnostics & Research names. NEO ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MTD |
Mettler Toledo International Inc/
|
3,240 | $4,139,132 | |
| 2 | DHR |
Danaher Corp /De/
|
16,459 | $3,135,110 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
1,864 | $934,535 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
1,055 | $555,394 | |
| 5 | ILMN |
Illumina, Inc.
|
897 | $157,719 | |
| 6 | VCYT |
Veracyte, Inc.
|
104 | $6,107 | |
| 7 | NEO |
Neogenomics Inc
This page
|
128 | $1,867 |
All Filings in NEO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,867 | 128 | Shares | Sole | 2026-08-18 | |
| No filing history on record for this holder in this stock. | ||||||